Decibel Therapeutics Public
Translating rapid advances in hearing science to meet the urgent needs of hundreds of millions worldwide with disabling hearing loss.
Technology:
Other
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Founded Date:
2015
Number Of Exists:
51-100
Last Funding Type:
Series D
Investors Number:
16
Last Funding Date:
2020
Estimated Revenue:
$10M to $50M
Employee Number:
51-100
Total Funding:
189.2M
Industry:
PharmTech
Investor Type:
IPO